In 2019, Hangzhou Qiming went public on the Hong Kong stock market. The era of Chinese valves has thus exploded.

In 2021, Hangzhou Zylox-Tonbridge was listed on the Hong Kong stock market. The "Neurological + Peripheral" dual engines have opened up new horizons for domestically produced vascular intervention.

A half-mu square pond opens like a mirror, the light of the sky and the shadows of clouds linger together.

If we define a city or an industry by its public listings, there is no doubt that Hangzhou's medical device circle at that time was filled with an upward fragrance. Amidst aspirations, the sound of one's own bell-ringing could be heard everywhere.

Wei Qiang Medical, established in 2016, is the closest one.

1. Wei Qiang

Speaking of Wei Qiang, it is inseparable from Qi Ming.

The spiritual attributes originate from Deno, while the physical attributes belong to MicroPort. With Deno's funding and MicroPort's people and product lineages, Wei Qiang Medical is very likely to be the latecomer challenging the "MicroPort duo" in the large stent track.

From Fabulous to Weflow, and then to iliac vein stents, Wei Qiang Medical's "extravascular" territory advances with its own steadfast direction and speed.

If "gazing at the stars + staying grounded" is used asGolden Model of InstrumentsLooking at it, on one side is innovative clinical practice, and on the other is solid sales. Wei Qiang Medical, with sales exceeding 100 million yuan in 2024, is undoubtedly a top-tier presence in China's domestically produced medical device field.

PersonNot Following the SkyCalculation, a common lament in the江湖.

The conflict between Qiming and Deno systems not only pushed the leading valve stock to the brink but also dismantled "Deno System," which could have become another pole of China's medical device industry. Wei Qiang Medical has been profoundly affected by this change.

In 2024, Wei Qiang Medical was acquired by Entai (Kangdelai).

2. Zylox-Tonbridge

It is also in 2024, Zylox-Tonbridge'sNet Profit Breaks Through 100 Million Yuan, compared to the million in 2023, it can be said to be a sudden change.

It has only been five years since Hangzhou's interventional device industry had its moment of glory. Qiming has dimmed, Wei Qiang Medical was sold, while Zylox-Tonbridge has been on a rapid rise. The pole of China's medical device industry once lost by the "Denovo System" is now steadily being taken over by Zylox-Tonbridge.

Hangzhou City is no stranger to tales of the past, and interventional devices carve their own stories.The strokes of horizontal, left-falling, vertical, and right-falling left their mark.

3. The Past Will Not Fade Away

Zylox-Tonbridge in 2012 and Tonbridge in 2016, upon closer inspection, are not the leaders in their respective fields. After going public in 2021, they also experienced a sharp decline in the Hong Kong stock market and were undervalued.

But who would have thought that, even under the dual pressure of peripheral and neural involution, it managed to "Dare to be the last in the world" in a powerful comeback.

The past of Zylox-Tonbridge is like a legendary tale in the medical江湖 (jianghu). With steady and forward-moving resilience, it has accumulated over a decade of persistent efforts, breaking through layers of crises, seizing opportunities, avoiding minor mistakes, and achieving its towering presence today.

This is a path that most companies cannot reach. Not making mistakes and being stable—these two points alone can block 90% of companies, let alone the comprehensiveness of its product layout and the foresight of its vision.

In 2024, Wei Qiang Medical experienced both joys and sorrows, weathering storms. From shareholder disputes to unpaid wages, rumors once spread that the company was on the verge of collapse. In the end, these rumors were dispelled one by one. During challenging times, the Wei Qiang team demonstrated unprecedented unity and trust.

Let the shareholders' matters be handled by the shareholders, and let the team's matters be handled by the team.

Wei Qiang Medical, with sales exceeding 100 million, has cut off its past in a phoenix-like self-immolation to merge with Ying Tai. The phoenix burns and then rises from the ashes. After all, such a wide range of products and such a resilient team.

Wei Qiang Medical, with another way of never giving up and resetting to rebirth, returns to the stage of medical devices. Perhaps, in spirit and body, there are still elements of Denuo and Lifetech, but the arrival of Ying Tai is like a heroic figure riding on a seven-colored auspicious cloud.

This is a mark of romanticism in the history of Hangzhou's medical device affairs.

4. Reflection and Learning

Zylox-Tonbridge, worthy of respect and learning for those in the medical device industry.

That is the fruition of long-termism and heroism. It is very likely to write an epic journey from vascular intervention to becoming a leading force in China's medical device industry, powered by one's own strength.

Wei Qiang Medical, worthy of respect and learning for those in the medical device industry.

Because the path of medical devices is fraught with peril, and we always yearn for comebacks and reversals, falls and rebirths. This is a spirit of determination, a heart full of fierce resolve. With its resilience, Wei Qiang Medical may also achieve another legendary pairing of domestically produced devices with Ying Tai.

How can the channel be so clear? Because it has a source of fresh water.

Product's Patient Demand Attributes, Company's Sales Profitability Attributes, the most solid part in the foundations of the two enterprises, and this solidity supports the promising future of the two enterprises.

Tail

Gong Er told Ye Wen:

"I have seen myself, and I have also seen the heavens and the earth, but unfortunately, I haven't seen all living beings. I haven't finished walking this path, and I hope you can continue it."

Ye Wen replied to Gong Er:

"There was never any enmity between us, only a bond of fate."

Gong Er always guards the "inner essence" of the Gong family's martial arts world, while Ip Man builds the "outer reputation" of the Wing Chun martial arts world. One looks back, the other moves forward; though their paths differ, ultimately, both reach the highest realm of martial arts with their own spirit: "seeing all beings."

Zylox-Tonbridge and Wei Qiang Medical continue to write new chapters for interventional devices in their own way in Hangzhou, China.

These strokes and lines represent not only their own identity, the universe, and all beings, but also the identity, the universe, and all beings of a group of China's interventional device enterprises.

The road ahead will undoubtedly be long, but with the flourishing developments in the medical field, China's path in medical devices will surely carve out its own eras of pride amidst the vibrant and diverse advancements.